Clinical Translation of Nanomedicine.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Chemical Reviews

• Publication date

  2015-06-19

• Fields of study

  Biology, Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1021/acs.chemrev.5b00116PMID 26088284PMCID PMC4607605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML

  2015cited by this paper
• Efficacy of CPX‐351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

  2015cited by this paper
• A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.

  2015cited by this paper
• Medical devices: US medical device regulation.

  2015cited by this paper
• Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

  2014cited by this paper
• Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer.

  2014cited by this paper
• Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.

  2014cited by this paper
• Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer

  2014cited by this paper
• Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer.

  2014cited by this paper
• Clinical development success rates for investigational drugs

  2014cited by this paper
• Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.

  2014cited by this paper
• Abstract CT210: A phase 1 study of BIND-014, a PSMA-targeted nanoparticle containing docetaxel, administered to patients with refractory solid tumors on a weekly schedule

  2014cited by this paper
• Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.

  2014cited by this paper
• Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications

  2014cited by this paper
• PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells

  2014cited by this paper
• Enhancing the Enhanced Recovery Program in Colorectal Surgery - Use of Extended-Release Epidural Morphine (DepoDur®)

  2014cited by this paper
• The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.

  2014cited by this paper
• A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

  2014cited by this paper
• Anthracycline-related cardiotoxicity in childhood cancer survivors

  2014cited by this paper
• Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.

  2014cited by this paper
• Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer

  2014cited by this paper
• Effect of combined treatment with the epirubicin‐incorporating micelles (NC‐6300) and 1,2‐diaminocyclohexane platinum (II)‐incorporating micelles (NC‐4016) on a human gastric cancer model

  2014cited by this paper
• A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

  2014cited by this paper
• Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016)

  2014cited by this paper
• Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?

  2014cited by this paper
• New use of metals as nanosized radioenhancers.

  2014cited by this paper
• Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma: A Brown University Oncology Group Study

  2014cited by this paper
• Polymer-drug conjugates: origins, progress to date and future directions.

  2013cited by this paper
• Tumor‐targeted chemotherapy with the nanopolymer‐based drug NC‐6004 for oral squamous cell carcinoma

  2013cited by this paper
• Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies

  2013cited by this paper
• Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma.

  2013cited by this paper
• Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.

  2013cited by this paper
• Application of liposomal technologies for delivery of platinum analogs in oncology

  2013cited by this paper
• Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.

  2013cited by this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cited by this paper
• A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

  2013cited by this paper
• Effect of Doxorubicin/Pluronic SP1049C on Tumorigenicity, Aggressiveness, DNA Methylation and Stem Cell Markers in Murine Leukemia

  2013cited by this paper
• An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal

  2013cited by this paper
• First 'breakthrough' drugs designated, but dilution worries linger

  2013cited by this paper
• A review of the current status of siRNA nanomedicines in the treatment of cancer.

  2013cited by this paper
• Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

  2013cited by this paper
• Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.

  2013cited by this paper
• Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors.

  2013cited by this paper
• Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

  2013cited by this paper
• Delivery materials for siRNA therapeutics.

  2013cited by this paper
• Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial

  2013cited by this paper
• First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

  2013cited by this paper
• Polymer therapeutics-prospects for 21st century: the end of the beginning.

  2013cited by this paper
• Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity

  2013cited by this paper
• A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.

  2013cited by this paper
• A randomized phase 2 study of temozolomide and bevacizumab or nab‐paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma

  2013cited by this paper
• Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

  2013cited by this paper
• High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.

  2013cited by this paper
• A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases

  2013cited by this paper
• Nab-paclitaxel/bevacizumab/carboplatin chemotherapy in first-line triple negative metastatic breast cancer.

  2013cited by this paper
• Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

  2013cited by this paper
• The big picture on nanomedicine: the state of investigational and approved nanomedicine products.

  2013cited by this paper
• Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

  2013cited by this paper
• A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

  2013cited by this paper
• Everolimus for Advanced Pancreatic Neuroendocrine Tumors

  2012cited by this paper
• Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.

  2012cited by this paper
• A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer

  2012cited by this paper
• Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.

  2012cited by this paper
• Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.

  2012cited by this paper
• Abstract LB-452: A phase I, open label, safety, pharmacokinetic and pharmacodynamic dose escalation study of BIND-014 given by IV infusion to patients with advanced or metastatic cancer

  2012cited by this paper
• Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs.

  2012cited by this paper
• Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer: A Phase 2 Trial

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Measurement of Mucosal Biomarkers in a Phase 1 Trial of Intravaginal 3% StarPharma LTD 7013 Gel (VivaGel) to Assess Expanded Safety

  2012cited by this paper
• Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

  2012cited by this paper
• Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.

  2012cited by this paper
• Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer.

  2012cited by this paper
• Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

  2012cited by this paper
• Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors

  2012cited by this paper
• Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine

  2012cited by this paper
• Vincristine Sulfate Liposome Injection

  2012cited by this paper
• Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

  2012cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.

  2012cited by this paper
• Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.

  2012cited by this paper
• Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

  2012cited by this paper
• Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib

  2012cited by this paper
• Nanoscale radiotherapy with hafnium oxide nanoparticles.

  2012cited by this paper
• Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer.

  2012cited by this paper
• Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.

  2011cited by this paper
• Everolimus for advanced pancreatic neuroendocrine tumors.

  2011cited by this paper
• Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

  2011cited by this paper
• A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

  2011cited by this paper
• Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

  2011cited by this paper
• Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect.

  2011cited by this paper
• Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.

  2011cited by this paper
• Neurotoxicity Caused by the Treatment with Platinum Analogues

  2011cited by this paper
• Beating cancer in multiple ways using nanogold.

  2011cited by this paper
• Cytotoxicity and physicochemical properties of hafnium oxide nanoparticles.

  2011cited by this paper
• Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

  2011cited by this paper
• A phase II trial of nab‐paclitaxel (ABI‐007) and carboplatin in patients with unresectable stage IV melanoma

  2011cited by this paper
• SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans

  2011cited by this paper
• A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.

  2011cited by this paper
• A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days

  2011cited by this paper
• A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer.

  2011cited by this paper

• Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan.

  2026cites this paper
• A Review on AI-Based Data-Driven Models for Optimization of Nanocarriers as Drug Delivery Systems.

  2026cites this paper
• Recent advances in the nanoparticle-based targeted cancer treatment: A review

  2026cites this paper
• Phyto-nanotherapeutics: An emerging frontier in advancing phytopharmaceuticals: Challenges and opportunities

  2026cites this paper
• Supramolecules for Pathogen Inhibition: From Polymers to Self-Assembled Nanosystems.

  2026cites this paper
• Silk-engineered bioactive nanoparticles for targeted alleviation of acute inflammatory disease via macrophage reprogramming

  2025cites this paper
• Facile Preparation of Crosslinked PEG‐Polypeptide Drug Nanocarriers Through Biphasic Polymerization of Crude N‐Carboxyanhydrides

  2025cites this paper
• Unravelling the endosomal escape of pH-responsive nanoparticles using the split luciferase endosomal escape quantification assay.

  2025cites this paper
• Advancing neuroimaging: novel manganese- and iron-based MRI contrast agents for cerebral ischemic diseases

  2025cites this paper
• Synergistic anticancer effects of carrier-free self-assembled doxorubicin and emodin nanoparticles in non-small cell lung cancer

  2025cites this paper
• Revolutionizing healthcare: the transformative potential of nanotechnology in medicine

  2025cites this paper
• Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer

  2025cites this paper
• Lipid-based nanomedicine for colorectal cancer: Progress and prospects

  2025cites this paper
• Micro-Nano Convergence-Driven Radiotheranostic Revolution in Hepatocellular Carcinoma.

  2025cites this paper
• Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy

  2025cites this paper
• Carrier-free single-molecule hypoxia-activated nanoprodrug of SN38 with ultrahigh drug loading for pancreatic cancer treatment.

  2025cites this paper
• Exosomes as natural vectors for therapeutic delivery of bioactive compounds in skin diseases

  2025cites this paper
• Injectable nanorobots for precision cancer therapy: motion-enhanced drug delivery.

  2025cites this paper
• Bioactive nanoparticles from plants: A novel strategy for cancer therapy

  2025cites this paper
• Recent Developments in Nanoparticle‐Hydrogel Hybrid Materials for Controlled Release

  2025cites this paper
• RECENT ADVANCES IN NANOCARRIERS FOR TARGETED CANCER THERAPY

  2025cites this paper
• Multifunctional gold nanoparticles: bridging detection, diagnosis, and targeted therapy in cancer

  2025cites this paper
• Radiolabeled Nanogels: From Multimodality Imaging to Combination Therapy of Cancer

  2025cites this paper
• Upholding hyaluronic acid's multi-functionality for nucleic acid drug delivery to target EMT in breast cancer.

  2025cites this paper
• Recent Advances in Nanoparticle-Based Antiretroviral Drug Delivery Systems for HIV Treatment and Prevention: A Comprehensive Review

  2025cites this paper
• Nanoliposome-based drug delivery systems for the treatment of diabetes mellitus: a review

  2025cites this paper
• Hematoporphyrin-Modified Dendrimers Combined Immunoadjuvants for Enhanced Photoimmunotherapy of Colorectal Cancer.

  2025cites this paper
• Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical Needs.

  2025cites this paper
• From Hype to Hope: Deconstructing the translational barriers and Charting a new roadmap for Ultrasound-Responsive nanobubbles.

  2025cites this paper
• Next generation nanoparticle protein corona characterization methods.

  2025cites this paper
• Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges

  2025cites this paper
• Shape-Dependent Entropic Forces Govern Synergistic Bystander Nanoparticle Uptake.

  2025cites this paper
• Innovations in skin cancer treatment: The role of nanotechnology and cellular biotechnology

  2025cites this paper
• Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy

  2025cites this paper
• Rational design and self-assembly of amphiphilic conjugated porphyrin small molecules for PDT/PTT synergistic therapy

  2025cites this paper
• Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3.

  2025cites this paper
• Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches

  2025cites this paper
• Liposome-Tagged Salmonella Vnp20009 for Hydroxy Tumor: A Review

  2025cites this paper
• Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

  2025cites this paper
• Advanced biomaterials for the targeted delivery of immune checkpoint inhibitors to solid tumors.

  2025cites this paper
• Advances in Doxorubicin Chemotherapy: Emerging Polymeric Nanocarriers for Drug Loading and Delivery

  2025cites this paper
• A hypoxia-leveraged near-IR theranostic nanomedicine enables imaging-guided tumor diagnosis and photothermal therapy.

  2025cites this paper
• Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy

  2025cites this paper
• Quality by digital design for accelerated sustainable nanomedicine development.

  2025cites this paper
• Nano-Liposomal Delivery Systems and their Applications in Bacterial Resistance

  2025cites this paper
• Extracellular Vesicles and Nanoparticles in Regenerative and Personalised Medicine: Diagnostic and Therapeutic Roles—A Narrative Review

  2025cites this paper
• Zebrafish as a versatile preclinical model for evaluating nanomedicine in biomedical research: Recent advances and applications

  2025cites this paper
• Nanotechnology‐Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives

  2025cites this paper
• Lab-in-the-loop machine learning for brain-targeting delivery system design

  2025cites this paper
• Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

  2025cites this paper
• Lipid Tail Length Determines Nano-Bio Interactions of Peptide Amphiphile Nanostructures

  2025cites this paper
• Functional gold nanoparticles in diagnosis and treatment of cancer: A systematic review

  2025cites this paper
• Benchmarking Protein Nanoparticles for Drug Delivery and Clinical Translation

  2025cites this paper
• Pure drug nanomedicines - where we are?

  2025cites this paper
• Construction and evaluation of a long-circulating thermosensitive liposomal black phosphorus quantum dot delivery system for osteosarcoma therapy.

  2025cites this paper
• "A perfect pair": extracellular vesicle-based novel strategies for precise cancer diagnosis and effective treatment.

  2025cites this paper
• Triethylamine-mediated protonation–deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis

  2025cites this paper
• Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy.

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Production of 5-fluorouracil-loaded PLGA nanoparticles with toroidal microfluidic system and optimization of process variables by design of experiments.

  2024cites this paper
• A spermine-responsive supramolecular chemotherapy system constructed from a water-soluble pillar[5]arene and a diphenylanthracene-containing amphiphile for precise chemotherapy.

  2024cites this paper
• Recent advances in polysulfide-based prodrug nanomedicines for cancer therapy

  2024cites this paper
• Polyethylene glycol-mediated functionalization of nanodelivery systems for improving their pharmacokinetic profile and anticancer efficacy

  2024cites this paper
• Nano-Bio Interfaces: Pioneering Targeted Approaches for Disease Treatment and Prevention

  2024cites this paper
• Alginate nanogel-embedded liposomal drug carriers facilitate drug delivery efficiency in arthritis treatment.

  2024cites this paper
• Clinical Translation of Inorganic Nanoparticles and Engineered Living Materials for Cancer Therapy.

  2024cites this paper
• Gold Nanoparticles as a Tool to Detect Biomarkers in Osteoarthritis: New Insights

  2024cites this paper
• A glance on gold nanoparticle: An emerging theranostic tool for oncology

  2024cites this paper
• Docosahexaenoic acid-loaded nanoparticles: A state-of-the-art of preparation methods, characterization, functionality, and therapeutic applications

  2024cites this paper
• Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery

  2024cites this paper
• STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition

  2024cites this paper
• Unraveling the Omega-3 Puzzle: Navigating Challenges and Innovations for Bone Health and Healthy Aging

  2024cites this paper
• Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection

  2024cites this paper
• Extracellular Vesicles-Mediated Bio-Orthogonal Catalysis in Growing Tumors

  2024cites this paper
• Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer

  2024cites this paper
• Polymeric Nanoparticles for Drug Delivery

  2024cites this paper
• Beyond surface modification strategies to control infections associated with implanted biomaterials and devices - Addressing the opportunities offered by nanotechnology.

  2024cites this paper
• Extracellular Vesicles-powered Immunotherapy: Unleashing the Potential for Safer and More Effective Cancer Treatment.

  2024cites this paper
• Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy

  2024cites this paper
• Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues

  2024cites this paper
• Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.

  2024cites this paper
• The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.

  2024cites this paper
• Potential Application Prospects of Biomolecule-Modified Two-Dimensional Chiral Nanomaterials in Biomedicine.

  2024cites this paper
• Novel Titanocene Y derivative with albumin affinity exhibits improved anticancer activity against platinum resistant cells.

  2024cites this paper
• Inhalable nanomedicine for lung cancer treatment

  2024cites this paper
• Cucurbit[8]uril-based supramolecular theranostics

  2024cites this paper
• Challenges and opportunities of poly(amino acid) nanomedicines in cancer therapy.

  2024cites this paper
• Physiological principles underlying the kidney targeting of renal nanomedicines

  2024cites this paper
• Polymer/iron oxide nanocomposites as magnetic resonance imaging contrast agents: Polymer modulation and probe property control

  2024cites this paper
• Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release.

  2024cites this paper
• Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer

  2024cites this paper
• Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.

  2024cites this paper
• MOLECULAR AND NANOPARTICULATE AGENTS FOR PHOTODYNAMIC THERAPY GUIDED BY NEAR INFRARED IMAGING

  2024cites this paper
• Recent Advances in Nanomodulators for Augmenting Cancer Immunotherapy in Cold Tumors: Insights from Drug Delivery to Drug‐Free Strategies

  2024cites this paper
• Advances and Prospects in Integrated Nano-oncology

  2024cites this paper
• Bone Targeting Nanoparticles for the Treatment of Osteoporosis

  2024cites this paper
• Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy

  2024cites this paper
• Revolutionizing eye care: the game-changing applications of nano-antioxidants in ophthalmology.

  2024cites this paper
• A Systematic Study on Long-acting Nanobubbles: Current Advancement and Prospects on Theranostic Properties

  2024cites this paper
• Evaluation of a targeted drug delivery system on breast tumor spheroids on a chip

  2024cites this paper